This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Early Registration Savings Deadline Expires In

  • 00
    DAYS
  • 00
    HRS
  • 00
    MINS
  • 00
    SECS
Delivered as a Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23Boston Convention and Exhibition Center
Menu
Book
keyboard_arrow_right

CONFERENCE DAY THREE - EST/EDT (Eastern Daylight, GMT-4)

keyboard_arrow_leftSearch & Filter
search

CONFERENCE DAY THREE - EST/EDT (Eastern Daylight, GMT-4)

search
8:25am - 8:30am5 mins
Cell & Gene Therapy Manufacturing and Commercialization – Partnering Track
Chairperson’s Opening Remarks
    8:30am - 9:00am30 mins
    Cell & Gene Therapy Manufacturing and Commercialization – Partnering Track
    State of the Industry
    • Janet Lambert - Chief Executive Officer, Alliance for Regenerative Medicine
    9:00am - 10:00am60 mins
    Cell & Gene Therapy Manufacturing and Commercialization – Partnering Track
    Panel Discussion: Exploring the Massachusetts Biotech Ecosystem; Fostering Innovation, Spinning out, & Maximising Growth Potential
    • Shashi Murthy, PhD - Founder & CTO, Flaskworks
    • Brian Goodman, PhD - Partner, MPM
    • Jennifer Griffin - VP Industrial Strategy & Investments, Mass Life Sciences
    • Sharon Cload - Vice President Discovery Biotherapeutics, Bristol Myers Squibb
    9:00am - 9:30am30 mins
    Bio fabrication – The Path to Commercialization: In collaboration with ARMI
    Opening remarks and Manufacturing the Future of Biofabrication with ARMI
    • Thomas Bollenbach - Chief Technology Officer, Advanced Regenerative Manufacturing Institute
    9:30am - 10:00am30 mins
    Bio fabrication – The Path to Commercialization: In collaboration with ARMI
    Tools and Technologies for Generating High Quality Cellular Starting Material
    • Carter Cliff - Founder & CEO, Vascugen Inc., USA
    10:00am - 10:45am45 mins
    Networking Refreshment Break
      10:45am - 11:30am45 mins
      Cell & Gene Therapy Manufacturing and Commercialization – Partnering Track
      Panel: Investment view on Innovation in Cell & Gene Therapy
      • Shaan Gandhi - Director, Northpond Ventures
      • Walter Kowtonuik - Principal, Third Rock
      • Shinichiro Fuse - Managing Director, MPM Capital
      • Michal Preminger, Ph.D., MBA - Head, J&J Innovation, East North America, J&J
      10:45am - 11:15am30 mins
      Bio fabrication – The Path to Commercialization: In collaboration with ARMI
      Streamlining Production of Defined Cell Lines
      • Paratsoo Khoshakhlagh, Ph.D. - Chief Executive Officer & Co-Founder, GC Therapeutics, USA
      11:15am - 11:45am30 mins
      Bio fabrication – The Path to Commercialization: In collaboration with ARMI
      Label-free Cell Selection and Purification
      • Travis Block - Chief Technology Officer, Cell X Technologies, USA
      11:30am - 12:30pm60 mins
      Cell & Gene Therapy Manufacturing and Commercialization – Partnering Track
      Dual Dialogue – Anatomy of an Acquisition: Bayer and AskBio
      • Sheila Mikhail - CEO & Co-Founder, AskBio
      • Marianne De Backer, MBA, PhD - EVP, Head of Strategy, BD&L, Bayer
      11:45am - 12:15pm30 mins
      Bio fabrication – The Path to Commercialization: In collaboration with ARMI
      Smart and Connected Bioreactor with Wireless Flexible Sensors and Electronics
      • W. Hong Yeo - Assistant Professor of George W. Woodruff School of Mechanical Engineering, Director of the IEN Center for Human-Centric Interfaces and Engineering, Georgia Institute of Technology, USA
      12:15pm - 12:30pm15 mins
      Bio fabrication – The Path to Commercialization: In collaboration with ARMI
      Spotlight Presentation
        12:30pm - 1:30pm60 mins
        Networking Luncheon
          1:30pm - 2:15pm45 mins
          Cell & Gene Therapy Manufacturing and Commercialization – Partnering Track
          Panel: Manufacturing and Distribution Strategies for Commercialising Cell & Gene Therapies
          • Anne Altmeyer - Formerly, CBO, Sigilon Tx
          • Kareem Reda - CBO, Elevate Bio
          • Maria Cho - VP Business Development & Corporate Strategy, Dendreon, USA
          1:30pm - 2:00pm30 mins
          Bio fabrication – The Path to Commercialization: In collaboration with ARMI
          Scaling the Production of Tissues Using 3D Printing
          • Mike Graffeo - CEO & Co-Founder, FluidForm, USA
          2:00pm - 2:30pm30 mins
          Bio fabrication – The Path to Commercialization: In collaboration with ARMI
          Generating Complex Scaffolds and Harnessing Native Material Architecture
          • Aleks Katane - Liver Program Manager, Miromatrix, USA
          2:15pm - 3:00pm45 mins
          Cell & Gene Therapy Manufacturing and Commercialization – Partnering Track
          Panel: Talent Acquisition, Development and Retention in Novel Therapeutics
          • Andrew Rigoglioso - Associate Director, Talent Acquisition, Cell Therapy Development & Operations, BMS
          • Juliette Hilliard - Director, Talent Acquisition, Novartis GT
          • Georgette Verdin - Chief HRO, Avrobio
          2:30pm - 3:00pm30 mins
          Bio fabrication – The Path to Commercialization: In collaboration with ARMI
          Maturation Techniques and Bioreactor Culture for Tissue Generation
          • Nathaniel Hogrebe - Postdoctoral Research Fellow, Jeffrey Millman Laboratory, Washington University School of Medicine, USA
          3:00pm - 3:30pm30 mins
          Networking Refreshment Break
            3:30pm - 4:15pm45 mins
            Cell & Gene Therapy Manufacturing and Commercialization – Partnering Track
            Panel: A Global View of Value, Regulatory Considerations & Access for Novel Therapies
            • Greg White - Senior Director , Global Market Access Policy, Janssen
            • Kristin Wolff - Senior Director, Global Government Affairs & Public Policy, Bluebird
            • Manal Morsy - Senior Vice President, Head Global Regulatory Affairs, Athersys, Inc.
            • Roland DeAngelis - SVP, Commercial Operations, Vericel (pernding final confirmation)
            3:30pm - 4:00pm30 mins
            Bio fabrication – The Path to Commercialization: In collaboration with ARMI
            Maturation Techniques and Bioreactor Culture for Tissue Generation
            • Jane Lebkowski - President, Regenerative Patch Technologies Inc., USA
            4:00pm - 4:30pm30 mins
            Bio fabrication – The Path to Commercialization: In collaboration with ARMI
            Trends for the Future of Biomanufacturing
              4:15pm - 5:00pm45 mins
              Cell & Gene Therapy Manufacturing and Commercialization – Partnering Track
              Panel: Patient Case Management & Developing Patient journey methods for Cell & Gene Therapies
              • Shefali Shah - Independent Consultant, Indi
              • Sarah Nikiforow - Asst. Professor, Stem Cell Transplantation Program, Asst. Medical Director, Cell Manipulation Core Facility, Dana-Farber Cancer Institute
              • Kris Elverum - SVP, BD & Strategy, Rubius Tx
              4:30pm - 5:00pm30 mins
              Bio fabrication – The Path to Commercialization: In collaboration with ARMI
              End of Day
                CONFERENCE DAY TWO
                Filter
                Streams
                Formats
                Choose Day